Trimedyne

HOME

ABOUT US

PRODUCTS

EDUCATION & TRAINING

INVESTOR RELATIONS

EVENTS

 

Company History

Management Team

Press Releases

Contact Us

Careers


Laser Spine Therapy
Provider List


 

 

FOR IMMEDIATE RELEASE

CONTACT: CRAIG SMITH

949.951.3800 EXT. 288
csmith@trimedyne.com
 

TRIMEDYNE ANNOUNCES REVENUES AND PROFITS FOR THE QUARTER AND FISCAL YEAR ENDED SEPT. 30, 2004 

       January 17, 2005 – Irvine, CA: TRIMEDYNE, INC. (OTCBB “TMED”) today announced its financial results for the quarter and fiscal year ended September 30, 2004.

       Revenues in the quarter ending September 30, 2004 were $1,623,000, compared with $1,624,000 in the same period of 2003.   Net income in the current quarter was $529,000 or $0.04 per share, compared with net income of $205,000 or $0.01 per share in the same period of 2003.  The current quarter’s net income includes the benefit of the reversal of $290,000 of the Company’s reserve for excess and obsolete inventory, due to an analysis of inventory turnover rates and projected future usages.  The effect of this reversal was a decrease in the Company’s cost of goods for the quarter, increasing net income.

       Revenues for the fiscal year ended September 30, 2004 were $5,973,000, compared with revenues of $6,459,000 in the prior fiscal year.  Net income in the fiscal year ended September 30, 2004 was $1,001,000 or $0.07 per share, compared with net income of $1,033,000 or $0.07 per share in the prior fiscal year.  The current year’s results include the benefit of the $290,000 inventory reserve reversal described above.

       Marvin P. Loeb, Chairman of Trimedyne, said, “We are pleased to report our second consecutive year of profitable operations.  We have been engaged in the development of several new products.  We hope one or more of these new products, whose development is almost completed, will enable us to increase our revenues and profits in 2005, although such cannot be assured.”

       Trimedyne manufactures lasers and proprietary fiber optic devices for a variety of minimally invasive surgical procedures, many of which are performed on an outpatient basis at substantially less cost than conventional surgery.  For product, financial and other information, visit Trimedyne's website, http://www.trimedyne.com.

 "Safe Harbor" Statement Under the Private Securities Litigation Reform Act:

       Statements in this news release may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1993 and Section 21E of the Securities and Exchange Act of 1934.  Such statements may involve various risks and uncertainties, some of which may be discussed in the Company's most recent report on Form 10-KSB and subsequently filed SEC reports.  There is no assurance any new products can be cleared for sale by the FDA or successfully commercialized or any forward-looking statements will prove accurate, as actual results and future events could differ materially from those presently anticipated.

*****

Back


Home | About Us | Products | Education & Training | Investor Relations | Events
  What's New | Careers | DoublePulse | Site Map | Contact Us

© Copyright 2005 Trimedyne, Inc.  All rights reserved.